Impact of Methylation of the Gene on Prognosis of Head and Neck Osteosarcoma |
Kim, Yong-Deok
(Department of Oral and Maxilofacial Surgery, School of Dentistry, Pusan National University)
Hwang, Dae-Seok (Department of Oral and Maxilofacial Surgery, School of Dentistry, Pusan National University) Kim, Cheol-Hoon (Department of Dentistry(OMFS), College of Medicine, Dong-A University) Shin, Sang-Hun (Department of Oral and Maxilofacial Surgery, School of Dentistry, Pusan National University) Kim, Uk-Kyu (Department of Oral and Maxilofacial Surgery, School of Dentistry, Pusan National University) Kim, Jong-Ryoul (Department of Oral and Maxilofacial Surgery, School of Dentistry, Pusan National University) Chung, In-Kyo (Department of Oral and Maxilofacial Surgery, School of Dentistry, Pusan National University) |
1 | Bartsch D, Shevlin DW, Gallery MP, et al.: Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation. J Natl Acad Sci USA 1996;88:680-682 |
2 | Nielsen GP, Burns KL, Rosenberg AE, et al.: CDKN2A gene deletions and loss of p16 expression occur in osteosarcoma that lack RB alterations. Am J Pathol 1998;153:159-163 DOI ScienceOn |
3 | Maelandsmo GM, Berner JM, Florenes VA, et al.: Homozygous deletion of the CDKN2 gene in human sarcomas: relationship to amplification and mRNA levels of CDK4 and CCND1. Br J Cancer 1995;72:393-398 DOI ScienceOn |
4 | Collins K, Jacks T, Pavletich NP: The cell cycle and cancer. Proc Natl Acad Sci USA 1997;94:2776-8 |
5 | Patino-Garcia A, Sierrasesumaga L: Analysis of P161NK4 and TP53 tumor supressor gene s in bone sarcoma pediatric patients. Cancer Genet Cytogenet 1997;98:50-5 DOI ScienceOn |
6 | Galindo CR, Shah N, McCarville MB, et al.: Outcome after local recurrence of osteosarcoma. Cancer 2004;100:1928-35 DOI ScienceOn |
7 | Kawaguchi K, Oda Y, Saito T, et al.: Mechanisms of inactivation of the gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methhylation and poor prognosis. J Pathol 2003;201:487-495 DOI ScienceOn |
8 | Dei Tos AP, Maestro R, Doglioni C, et al.: Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol 1996;148:1037-1045 |
9 | Gonzales-Zulueta M, Bender CM, Yang AS, et al.: Methylation of the 5'CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed tissues correlates with gene silencing. Cancer Res 1995;55:4531-4535 |
10 | Toguchida J, Ishizaki K, Sasaki MS, et al.: Chromosonal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 1988;48:3939-43 |
11 | Reed JA, Loganzo F Jr, Shea CR, et al.: Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 1995;55:2713-2718 |
12 | Merlo A, Herman JG, Mao L, et al.: 5'CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancer. Nature Med 1995;1:686-692 DOI |
13 | Wei G, Lonardo F, Ueda T, et al.: CDK4 gene amplification in osteo sarcoma: reciprocal relationship with gene alterations and mapping of 12q13 amplicons. Int J Cancer 1999;80:199-204 DOI ScienceOn |
14 | Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366:704-707 DOI ScienceOn |
15 | Nobori T, Miura K, Wu DJ, et al.: Deletions of the cyclindependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-756 DOI ScienceOn |
16 | Benassi MS, Molendini L, Gamberi G, et al.: Alteration of pRB/p16/cdk4 regulation in human osteosarcoma. Int J Cancer 1999;84:489-493 DOI ScienceOn |
17 | Xu J, Yang G, Bu H, et al.: Detection of methylation status of p16 tumor suppressor gene in soft tissue leiomyosarcoma. Zhonghua Bing Li Xue Za Zhi 2001;30:16-18 |
18 | Yamaguchi T, Toguchida J, Yamamuro T, et al.: Allelotype analysis in osteo- sarcomas: frequent allele loss on 3q,13q,17p,and 18q. Cancer Res 1992;52:2419-23 |
19 | Kratzke RA, Greatens TM, Rubins JB, et al.: Rb and expression in resected non-small cell lung tumors. Cancer Res 1996;56:3415-3420 |
20 | Maitra A, Roberts H, Weinberg AG, et al.: Loss of p16INK4 expression correlates with decreased survival in pediatric osteosarcomas. Int J Cancer 2001;95:34-38 DOI ScienceOn |
21 | Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81 DOI |
22 | Herman JG, Graff JR, Myohanen S, et al.: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-9826 DOI |
23 | Takeuchi H, Ozawa S, Ando N, et al.: Altered p16/MTSI/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of esophagus. Clin Cancer Res 1997;3:2229-2236 |
24 | Sherr CJ: Cancer cell cycles. Science 1996;274:1672-1677 DOI ScienceOn |
25 | Tete PH, Bird AP: Effects of DNA methylation on DNAbinding proteins and gene expression. Curr Opin Genet Dev 1993;3:226-231 DOI ScienceOn |
26 | Wunder JS, Czitrom AA, Kandel R, et al.: Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst 1991;83:194-200 DOI |
27 | Bartkova J, Lukas J, Bartek J: Aberrations of the G1- and G1/S-regulating genes in human cancer. Prog Cell Cycle Res 1997;3:211-20 |
28 | Wadayama B, Toguchida J, Shimizu T, et al.: Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 1994;54:3042-8 |
29 | Condon-Cardo C: Mytation of cell cycle regulators. Biological and clinical implication for human neoplasia. Am J Pathol 1995;147:545-560 |
30 | Belchis DA, Meece CA, Benko FA, et al.: Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomas. Diagm Mol Pathol 1996;5:214-9 DOI |
31 | Benassi MS, Molendini L, Gamberi G, et al.: Involvement of gene products in the pathogenesis and development of human osteosarcoma. Cancer 2001;15:3062-3067 |
32 | Wei G, Antonescu CR, de Alava E, et al.: Prognostic impact of deletion in Ewing sarcoma. Cancer 2000;89:793-799 DOI ScienceOn |
33 | Burri N, Shaw P, Bouzourene H, et al.: Methylation silencing and mutations of the p14ARF and genes in colon cancer. Lab Invest 2001;81:217-229 DOI ScienceOn |
34 | Feugeas O, Guriec N, Babin-Boilletot A, et al.: Loss of heterozygosity of the RB gene is poor prognostic factor in patients with osteosarcoma. J Clin Oncol 1996;14:467-72 DOI |
35 | Geradts J, Wilson PA: High frequency of aberrant expression in human breast cancer. Am J Pathol 1996;149:1-6 |
36 | Bartek J, Lukas J, Bartkova J: Perspective:defects in cell cycle control and cancer. J Pathol 1999;187:95-9 DOI ScienceOn |
37 | Chang HW, Ling GS, Yuen AP: Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer 2004;101:125-32 DOI ScienceOn |
38 | Orlow I, Drobnjak M, Zhang Z, et al.: Alteration of and INK4B genes in adult soft tissue sarcomas: effect on survival. J Natl Cancer Inst 1999;91:73-79 DOI ScienceOn |
39 | Lopez-Guerrero JA, Pellin A, Noguera R, et al.: Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest 2001;81:803-814 DOI ScienceOn |
40 | Miller CW, Aslo A, Campbell MJ, et al.: Alterations of the p15, p16, and p18 genes in osteosarcoma. Cancer Genet Cytogenet 1996;86:136-142 DOI ScienceOn |
41 | Geradts J, Kratzke RA, Niehans G, et al.: Immunohistochemical detction of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product in archival human solid tumor: correlation with retinoblastoma protein expression. Cancer Res 1995;55:6006-6011 |
42 | Miller CW, Aslo A, Won A, gene: Alteration of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol 1996;122:559-65 DOI |